[1] Martins PS,Mello RR,Silva KS. Bronchopulmonary dysplasia as a predictor factor for motor alteration at 6 months corrected age in premature infants [J]. Arq Neuropsiquiatr,2010,68(5):749-754. [2] Gortner L,Misselwitz B,Milligan D,et al. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe:results from the MOSAIC cohort [J]. Neonatology,2011,99(2):112-117. [3] Lu HY,Shao GB,Li WB,et al. Effects of hyperoxia on transdifferentiation of primary cultured typeⅡ alveolar epithelial cells from premature rats [J]. In Vitro Cell Dev Biol Anim,2011,47(1):64-72. [4] Gewandter JS,Staversky RJ,O'Reilly MA. Hyperoxia augments ER stress induced cell death independent of BiP loss [J]. Free Radic Biol Med,2009,47(12):1742-1752. [5] Lozon TI,Eastman AJ,Matute-Bello G,et al. PKR-dependent CHOP induction limits hyperoxia-induced lung injury [J]. Am J Physiol Lung Cell Mol Physiol,2011,300(3):L422- L429. [6] Xu D,Perez RE,Rezaiekhaligh MH,et al. Knockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosis [J]. Am J Physiol Lung Cell Mol Physiol,2009,297(1):44-51. [7] Mulugeta S,Maguire JA,Newitt JL,et al. Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms [J]. Am J Physiol Lung Cell Mol Physiol,2007,293(3):L720- L729. [8] Zhong Q,Zhou B,Ann DK,et al. Role of ER stress in EMT of alveolar epithelial cells:effects of misfolded surfactant protein [J]. Am J Respir Cell Mol Biol,2011,45(3):498-509. [9] Greenhouqh A,Premkumar M,Patel D. Ventilatory strategies for the extremely premature infant [J]. Paediatr Anaesth,2008,18 (5):371-377. [10] Lavoie PM,Dube MP. Genetics of bronchopulmonary dysplasia inthe age of genomics [J]. Curr Opin Pediatr,2010,22(2):134-138. [11] Bhandari A,Bhandari V. Pitfalls,problems,and progress in bronchopulmonary dysplasia [J]. Pediatrics,2009,123(6):1562-1573. [12] Thomas W,Speer CP. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence? [J]. Neonatology,2008,94(3):150-159. [13] Schmidt B,Roberts R,Millar D,et al. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in verylow-birth-weight infants [J]. Neonatology,2008,93(4):284-287. [14] Erpenbeck VJ,Schmidt R,Gunther S,et al. Surfactant protein levels in bronchoalvelar lavage after segmental allergen challenge in patients with asthma [J]. Allergy,2006,61(5):598-604. [15] Bridges JP,Xu Y,Na CL,et al. Adapation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C [J]. J Cell Biol,2006,172(3):395-407. [16] Marcinak SJ,Ron D. The unfolded protein response in lung disease [J]. Proc Am Thorac Soc,2010,7(6):356-362.